CoChat

Connecting aging biology and inflammation in the omics era

Open access
Walker, Keenan A., Basisty, Nathan, Wilson, David M., Ferrucci, Luigi · 2022 · Journal of Clinical Investigation

The DOI matches its Crossref record; 189 of the 189 references it cites were found in a registry or an index; 134 of the 214 sources its claims cite were checked for support.

Abstract

Aging is characterized by the accumulation of damage to macromolecules and cell architecture that triggers a proinflammatory state in blood and solid tissues, termed inflammaging. Inflammaging has been implicated in the pathogenesis of many age-associated chronic diseases as well as loss of physical and cognitive function. The search for mechanisms that underlie inflammaging focused initially on the hallmarks of aging, but it is rapidly expanding in multiple directions. Here, we discuss the threads connecting cellular senescence and mitochondrial dysfunction to impaired mitophagy and DNA damage, which may act as a hub for inflammaging. We explore the emerging multi-omics efforts that aspire to define the complexity of inflammaging - and identify molecular signatures and novel targets for interventions aimed at counteracting excessive inflammation and its deleterious consequences while preserving the physiological immune response. Finally, we review the emerging evidence that inflammation is involved in brain aging and neurodegenerative diseases. Our goal is to broaden the research agenda for inflammaging with an eye on new therapeutic opportunities.

Overview

CoChat Summary

TL;DR

This review argues that inflammaging arises from intertwined aging hallmarks—cellular senescence, mitochondrial dysfunction, impaired mitophagy, and DNA damage—and can be dissected with multi-omics approaches. It surveys evidence linking these processes to age-related disease and brain aging, while highlighting unresolved questions about biomarkers, causality, and therapeutic targeting.

Key findings

  • Cellular senescence and the SASP are presented as key drivers of local and systemic inflammation, contributing to conditions such as atherosclerosis, osteoarthritis, cancer, pulmonary fibrosis, Alzheimer’s disease, Parkinson’s disease, and insulin resistance; senescent immune cells may also drive aging of solid organs.
  • Mitochondrial dysfunction is described as a nexus linking impaired mitophagy, DNA damage, NAD+ depletion, and inflammatory pathways including NLRP3, cGAS/STING, and NF-κB; DNA of mammalian cells experiences over 10^5 modifications per day, many ROS-related single-strand breaks.
  • Multi-omics studies are beginning to resolve inflammation subtypes: a PCA of 19 proteins identified two immune-signaling components, and an inflammatory age score derived from 73 plasma and CSF proteins accounted for approximately 40% of the variance in chronological age and was associated with AD dementia, AD pathology, and lower cognition.
  • Genetic contributions to immune traits vary widely: one large-scale GWAS found a median heritability of 37% for a broad set of immune cell types and traits, with some phenotypes as high as 96%; serum cytokine/chemokine heritability ranges from 50% to 90% in healthy twins aged 8–82 years, and TNF-α variance explained by genome-wide SNP data was more than 70% after fungal stimulation and more than 50% after LPS stimulation.

Methods

  • Narrative review; no primary experimental design, sample, or statistical analysis is reported.
  • Synthesizes evidence from animal models, human cohort studies, clinical trials, multi-omics/proteomic platforms, single-cell RNA sequencing, and genetic studies.
  • Thematically organized around cellular senescence/SASP, age-related mitochondrial dysfunction, multi-omics approaches to inflammaging, and inflammation in brain aging and neurodegenerative disease.

Limitations

  • The paper states that the robustness and generalizability of developed inflammatory signatures are not ready for clinical applications; that a causal role for cellular senescence in neurodegenerative disease has yet to be established; that the extent to which neuroinflammation is protective or pathogenic is unknown; and that attempts to distinguish beneficial from pathological senescence at proteome, transcriptome, and functional levels have not been successful.
  • The paper also notes limitations of current large-scale proteomic approaches, including platform-specific measurement variation, incomplete target validation, a bias toward secreted proteins, and limited breadth of protein measurement.
  • Evident from the text: this is a narrative review without a systematic search strategy or meta-analysis, and its topic selection is explicitly focused on a few areas rather than being exhaustive.

Model-written summary. Check it against the paper before relying on it.

Integrity signals

Registry

Crossref · 10.1172/jci158448

Cites

189 of 189 references verified0 citation errors · 0 not checkable

Statistics

Nothing to recompute.

Figures

Figure 1 Interplay between cellular senescence, mitochondrial dysfunction, and the aging immune system. During aging, increasing dysfunctional mitochondria contribute to inflammation through several pathways and interact with other hallmarks of aging such as cellular senescence and autophagy. Mitochondrial-derived damage-associated molecular patterns (mtDAMPs) accumulate in the cytosol, including mitochondrial DNA (mtDNA), oxidized mtDNA (ox-mtDNA), and cardiolipin. Accumulation of mtDAMPs leads to downstream production of inflammatory cytokines, type I interferons (IFNs), and chemokines via intracellular pattern recognition receptors to activate an immune response. The collective secretion of mtDAMPs, IFNs, cytokines, and chemokines into the extracellular environment contributes to inflammaging. With age, an increasing mitochondrial dysfunction and production of ROS lead to increased levels of senescent cells, which accumulate naturally with age and in response to multiple stimuli. The accumulation of senescent cells and the SASP increases the release of bioactive molecules, including cytokines, recruitment factors, and DAMPs, into circulation, thereby driving inflammaging. In turn, the accumulation of senescent lymphocytes in the aging immune system further propagates cellular senescence in peripheral tissues.
Figure 1 Interplay between cellular senescence, mitochondrial dysfunction, and the aging immune system. During aging, increasing dysfunctional mitochondria contribute to inflammation through several pathways and interact with other hallmarks of aging such as cellular senescence and autophagy. Mitochondrial-derived damage-associated molecular patterns (mtDAMPs) accumulate in the cytosol, including mitochondrial DNA (mtDNA), oxidized mtDNA (ox-mtDNA), and cardiolipin. Accumulation of mtDAMPs leads to downstream production of inflammatory cytokines, type I interferons (IFNs), and chemokines via intracellular pattern recognition receptors to activate an immune response. The collective secretion of mtDAMPs, IFNs, cytokines, and chemokines into the extracellular environment contributes to inflammaging. With age, an increasing mitochondrial dysfunction and production of ROS lead to increased levels of senescent cells, which accumulate naturally with age and in response to multiple stimuli. The accumulation of senescent cells and the SASP increases the release of bioactive molecules, including cytokines, recruitment factors, and DAMPs, into circulation, thereby driving inflammaging. In turn, the accumulation of senescent lymphocytes in the aging immune system further propagates cellular senescence in peripheral tissues.CC BY · PubMed Central
Figure 2 Mitochondria are hubs of inflammation. Mitochondria are at the center of three inflammatory mechanisms: the NLRP3 inflammasome, cGAS/STING pathway, and NF-κB pathway. NLRP3 inflammasome activation is considered a two-step process: First, priming requires activation of NF-κB by PAMPs or DAMPs binding to pattern recognition receptors including TLRs or by cytokines, such as TNF-α or IL-1β, via their receptors. NF-κB stimulates the transcription and posttranslational stabilization of inactive forms of NLRP3, precursors of cytokines pro–IL-1β and pro–IL-18, and other NF-κB–related cytokines such as IL-6. Second, during activation, a multitude of DAMPs, such as ATP, cholesterol crystals, and urate crystals, promote inflammasome assembly, involving NIMA-related kinase 7 (NEK7), a sensor of K+ efflux (180). The activation likely requires K+ efflux, ROS production, and relocalization of cardiolipin to the outer mitochondrial membrane. It has been proposed that all stimuli that trigger the NRLP3 inflammasome converge on mitochondria, possibly via release of newly synthesized oxidized mtDNA, but K+ efflux may also be critical (181, 182). NLRP3 activation causes activation of caspase-1 and cleavage of pro–IL-1β and pro–IL-18 to their activated forms. Caspase-1 also cleaves gasdermin D (GSDMD), which oligomerizes to form pores in the cell membrane, which may lead to extracellular release of IL-1 and IL-18, K+ efflux, and massive swelling with membrane rupture (pyroptosis). The DNA sensor cGAS binds to mtDNA released into the cytosol and catalyzes production of the secondary messenger cyclic GMP-AMP (cGAMP) from ATP and GTP. cAGMP binds to the ER membrane adaptor STING, which is displaced to the perinuclear endosome and activates TANK binding kinase 1 (TBK1), which, in turn, phosphorylates interferon regulatory factor 3 (IRF3) that enters the nucleus and enhances transcription of type I IFN and IFN-stimulated genes (ISGs), while also activating NF-κB. In cell culture, cGAS overexpression induces IFN-β, whereas cGAS knockdown erases IFN-β induction by DNA transfection (183). cGAS/STING activation also enhances autophagy (184) and induces cellular senescence (185). NF-κB is activated by diverse stress signals and pathways related to defense and survival (89, 186). Multiple stress signals activate the NF-κB dimer (composed of p65/p50 subunits) that translocates to the nucleus, where it binds to consensus sequences in regulatory regions of target genes (187). NF-κB activation drives multiple pleiotropic effects, including enhancing the transcription of proinflammatory mediators, such as TNF-α and IL-6, that regulate both innate and adaptive immunity (95). CARD, caspase recruitment domain; GSDMDNterm, GSDMD amino-terminal cell death domain; LRR, leucine-rich repeat; PYD, pyrin domain.
Figure 2 Mitochondria are hubs of inflammation. Mitochondria are at the center of three inflammatory mechanisms: the NLRP3 inflammasome, cGAS/STING pathway, and NF-κB pathway. NLRP3 inflammasome activation is considered a two-step process: First, priming requires activation of NF-κB by PAMPs or DAMPs binding to pattern recognition receptors including TLRs or by cytokines, such as TNF-α or IL-1β, via their receptors. NF-κB stimulates the transcription and posttranslational stabilization of inactive forms of NLRP3, precursors of cytokines pro–IL-1β and pro–IL-18, and other NF-κB–related cytokines such as IL-6. Second, during activation, a multitude of DAMPs, such as ATP, cholesterol crystals, and urate crystals, promote inflammasome assembly, involving NIMA-related kinase 7 (NEK7), a sensor of K+ efflux (180). The activation likely requires K+ efflux, ROS production, and relocalization of cardiolipin to the outer mitochondrial membrane. It has been proposed that all stimuli that trigger the NRLP3 inflammasome converge on mitochondria, possibly via release of newly synthesized oxidized mtDNA, but K+ efflux may also be critical (181, 182). NLRP3 activation causes activation of caspase-1 and cleavage of pro–IL-1β and pro–IL-18 to their activated forms. Caspase-1 also cleaves gasdermin D (GSDMD), which oligomerizes to form pores in the cell membrane, which may lead to extracellular release of IL-1 and IL-18, K+ efflux, and massive swelling with membrane rupture (pyroptosis). The DNA sensor cGAS binds to mtDNA released into the cytosol and catalyzes production of the secondary messenger cyclic GMP-AMP (cGAMP) from ATP and GTP. cAGMP binds to the ER membrane adaptor STING, which is displaced to the perinuclear endosome and activates TANK binding kinase 1 (TBK1), which, in turn, phosphorylates interferon regulatory factor 3 (IRF3) that enters the nucleus and enhances transcription of type I IFN and IFN-stimulated genes (ISGs), while also activating NF-κB. In cell culture, cGAS overexpression induces IFN-β, whereas cGAS knockdown erases IFN-β induction by DNA transfection (183). cGAS/STING activation also enhances autophagy (184) and induces cellular senescence (185). NF-κB is activated by diverse stress signals and pathways related to defense and survival (89, 186). Multiple stress signals activate the NF-κB dimer (composed of p65/p50 subunits) that translocates to the nucleus, where it binds to consensus sequences in regulatory regions of target genes (187). NF-κB activation drives multiple pleiotropic effects, including enhancing the transcription of proinflammatory mediators, such as TNF-α and IL-6, that regulate both innate and adaptive immunity (95). CARD, caspase recruitment domain; GSDMDNterm, GSDMD amino-terminal cell death domain; LRR, leucine-rich repeat; PYD, pyrin domain.CC BY · PubMed Central
Figure 3 The role of inflammation in neurovascular and brain aging. (i) Aging is associated with tissue-specific increases in proinflammatory protein expression, resulting in greater levels of inflammatory mediators (cytokines and chemokines) in peripheral circulation (blood). (ii) Inflammatory cytokines in blood signal cytokine receptors expressed in brain endothelial cells. This results in increased blood-brain barrier permeability and an upregulation of cellular adhesion molecules such as VCAM1. (iii) Inflammatory cytokines signal cytokine receptors on the luminal side of brain endothelial cells, leading to proinflammatory activation and leukocyte adhesion to vascular adhesion molecules, both of which promote proinflammatory endothelial activation. Together, these processes lead to an increased expression of inflammatory proteins in the brain parenchyma. (iv) Inflammatory proteins in the brain parenchyma can influence microglia and astrocyte phenotypes. For example, initial exposure of microglia to inflammatory mediators causes a transition from a surveilling homeostatic phenotype to an intermediate or activated phenotype. (v) Prolonged exposure to inflammatory signaling is believed to cause long-term microglial priming, characterized by exaggerated cytokine expression, reduced chemotaxis, and deficient phagocytosis. Primed microglia are more prone to aberrant expression in the context of disease. (vi) DNA damage, mitochondrial dysfunction, exposure to proteinaceous aggregates, and other forms of cellular stress can promote senescence of cells within the central nervous system, including brain endothelial cells and microglia. GFAP, glial fibrillary acidic protein; ICAM1, intercellular adhesion molecule 1; IL-1R1, IL-1 receptor type 1.
Figure 3 The role of inflammation in neurovascular and brain aging. (i) Aging is associated with tissue-specific increases in proinflammatory protein expression, resulting in greater levels of inflammatory mediators (cytokines and chemokines) in peripheral circulation (blood). (ii) Inflammatory cytokines in blood signal cytokine receptors expressed in brain endothelial cells. This results in increased blood-brain barrier permeability and an upregulation of cellular adhesion molecules such as VCAM1. (iii) Inflammatory cytokines signal cytokine receptors on the luminal side of brain endothelial cells, leading to proinflammatory activation and leukocyte adhesion to vascular adhesion molecules, both of which promote proinflammatory endothelial activation. Together, these processes lead to an increased expression of inflammatory proteins in the brain parenchyma. (iv) Inflammatory proteins in the brain parenchyma can influence microglia and astrocyte phenotypes. For example, initial exposure of microglia to inflammatory mediators causes a transition from a surveilling homeostatic phenotype to an intermediate or activated phenotype. (v) Prolonged exposure to inflammatory signaling is believed to cause long-term microglial priming, characterized by exaggerated cytokine expression, reduced chemotaxis, and deficient phagocytosis. Primed microglia are more prone to aberrant expression in the context of disease. (vi) DNA damage, mitochondrial dysfunction, exposure to proteinaceous aggregates, and other forms of cellular stress can promote senescence of cells within the central nervous system, including brain endothelial cells and microglia. GFAP, glial fibrillary acidic protein; ICAM1, intercellular adhesion molecule 1; IL-1R1, IL-1 receptor type 1.CC BY · PubMed Central

Verification

Claims the paper makes

77 Valid · 2 Not valid · 47 Not checked · 25 Own results and interpretations

87 more claims · 60 with their cited sources checked

Create a free account to see all 151 claims and to verify the 80 references still open.

See all claims — free account
  • It may state two separate claims as one. 55
  • Probably not a substantial claim. 6

Create a free account to see these claims.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 189 references

Cited by

See all 190

Metadata

Authors
Walker, K. A., Basisty, N., Wilson, D. M., & Ferrucci, L.
Affiliations
  • National Institutes of Health (US)
  • Hasselt University (BE)
Corresponding author
Ferrucci, Luigi
Venue
Journal of Clinical Investigation
Published
2022-07-15
Volume
132
Issue
14
ISSN
  • 0021-9738 (ISSN-L)
  • 1558-8238
OpenAlex
W4285385649
Cited by
189
References
189
Citations by year
2026: 39 · 2025: 61 · 2024: 47 · 2023: 36 · 2022: 6
FWCI
3.21
Type
journal article
Language
en
Open access
Locations
  • Journal of Clinical Investigation (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
  • Document Server@UHasselt (UHasselt) (submittedVersion, other-oa)
Funders
  • Office of Dietary Supplements
  • National Institutes of Health
  • National Institute on Aging
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Inflammasome and immune disorders
Keywords
inflammaging, aging, cellular senescence, mitochondrial dysfunction, mitophagy, DNA damage, hallmarks of aging, multi-omics, brain aging, neurodegenerative diseases, anti-inflammatory therapy
MeSH terms
Aging, Biology, DNA Damage, Humans, Inflammation, Cellular Senescence

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

The claim verdicts this report counts are experimental: their accuracy is not yet measured.

A language model drew the claims from the paper on 2026-10-05, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).

A second model labelled each claim on 2026-10-05 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).

Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Connecting aging biology and inflammation in the omics era. https://app.cochat.ai/papers/10.1172/jci158448
The paper
Walker, K. A., Basisty, N., Wilson, D. M., & Ferrucci, L. (2022). Connecting aging biology and inflammation in the omics era. Journal of Clinical Investigation. https://doi.org/10.1172/jci158448

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.